Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: firstname.lastname@example.org. Type 508 Accommodation in the subject line of e-mail.
The Surgeon General's 1990 Report on the Health Benefits of Smoking Cessation Executive Summary - INTRODUCTION, OVERVIEW, AND CONCLUSIONS
The 1964 Report of the Surgeon General's Advisory Committee on Smoking and Health (US PHS 1964) concluded that cigarette smoking is a cause of lung cancer and laryngeal cancer in men, a probable cause of lung cancer in women, and the most important cause of chronic bronchitis. Other diseases, including emphysema and cardiovascular disease, also were found to be associated with cigarette smoking, although the evidence available at that time was not viewed as sufficient to establish the associations as causal. Even in 1964, however, the evidence for adverse health consequences of cigarette smoking was sufficient for the Committee to conclude that cigarette smoking is a health hazard of sufficient importance in the United States to warrant appropriate remedial action (US PHS 1964, p. 33).
Subsequent reports of the Surgeon General on smoking and health expanded and strengthened the conclusions of the 1964 Report on active smoking and documented the benefits of smoking cessation. (See US DHHS 1989 for review.) For some diseases, such as cardiovascular disease, newer evidence warranted a determination that associations with cigarette smoking were causal. Further associations of cigarette smoking with disease were identified, and involuntary (passive) smoking was found to be a cause of disease in nonsmokers (US DHHS 1986). Although cigarette smoking has been investigated intensively since the 1950s, new associations of smoking with adverse effects continue to be identified. For example, in a recent study smoking was associated with cataracts (West et al. 1989).
Evidence substantiates cigarette smoking as a cause of disease in smokers and, through involuntary smoking, in never smokers as well. This evidence has motivated the implementation of diverse and far-reaching programs for smoking prevention and cessation. The proportion of U.S. adults who smoke decreased substantially since the 1964 Report. In 1965, 29.6 percent of persons who had ever smoked had quit; by 1987, this percentage had increased to 44.8, representing more than 38 million adults. As the numbers of formerly smoking adults increased in the United States and other countries (US DHHS 1989), epidemiologic and clinical studies provided increasingly extensive information on the health benefits of smoking cessation. Thus, the 1964 Report noted that former smokers had lower overall mortality rates and lower lung cancer risk than current smokers, but the cited evidence was limited. Scientific data are now available on the consequences of cessation for most smoking-related diseases. Major benefits have been shown for overall mortality and for many specific diseases. Although past reports have considered much of the evidence, these data have not received a comprehensive and unified review. This Report systematically reviews the findings on the health benefits and consequences of cessation.
This Report includes a Foreword by the Assistant Secretary for Health and the Director of the Centers for Disease Control, a Preface by the Surgeon General of the U.S. Public Health Service, and the following chapters:
Chapter 1. Introduction, Overview, and Conclusions Chapter 2. Assessing Smoking Cessation and Its Health Consequences
Chapter 3. Smoking Cessation and Overall Mortality and Morbidity
Chapter 4. Smoking Cessation and Respiratory Cancers Chapter 5. Smoking Cessation and Nonrespiratory Cancers Chapter 6. Smoking Cessation and Cardiovascular Disease Chapter 7. Smoking Cessation and Nonmalignant Respiratory Diseases
Chapter 8. Smoking Cessation and Reproduction Chapter 9. Smoking, Smoking Cessation, and Other Nonmalignant Diseases
Chapter 10. Smoking Cessation and Body Weight Change Chapter 11. Psychological and Behavioral Consequences and Correlates of Smoking Cessation
Volume Appendix. National Trends in Smoking Cessation A key to acronyms and terms used throughout the Report is found at the end of the volume.
Other publications of the Public Health Service have reviewed determinants of smoking cessation and abstinence (US DHEW 1979; US DHHS 1980, 1988) and methods of smoking cessation and relapse prevention (Schwartz 1987; US DHHS 1988); hence, these topics are not covered in this Report.
Beginning with the 1964 Report, the evidence on active smoking and disease has been reviewed for causality to evaluate the associations of smoking with disease. The explicit criteria used in this evaluation include the consistency, strength, specificity, temporal relationship, and coherence of the association (US PHS 1964; US DHHS 1989). These criteria have provided a consistent and effective framework for examining the epidemiologic, clinical, and experimental data on active smoking. Although the criteria cannot be applied in the same fashion to associations of smoking cessation with changes in disease occurrence, the criteria of consistency, an appropriate temporal relationship, and coherence must be maintained with evidence on smoking cessation and health.
Thus, this Report examines data for consistency among investigations of the associations of cessation with disease occurrence and other outcomes, and considers the biologic plausibility of the known or presumed associations in the context of the mechanisms by which cigarette smoking is known or thought to cause disease. The appropriate time sequence of cessation with its effect is evident; cessation must always precede its presumed effect. In an observational study, this sequence may be reversed by the tendency of persons with initial symptoms of a cigarette-related disease or with frank disease to reduce cigarette consumption or to stop smoking (Chapter 2). The findings of longitudinal studies among former smokers document high mortality rates among short-term former smokers, which is consistent with reversal of the causal sequence of cessation followed by reduced disease occurrence; that is, disease has caused a change in exposure (Rogot and Murray 1980).
Cigarette smoke in its gaseous and particulate phases contains thousands of agents, many of which can damage tissues and cause disease (US DHEW 1979; US DHHS 1986, 1989). The pathogenetic mechanisms by which cigarette smoking causes disease are diverse, ranging from longer term processes, such as carcinogenesis, to shorter term processes, such as interference with tissue oxygenation by carbon monoxide. Thus, the biologic context in which the evidence on cessation is considered must be disease-specific; a unified biologic framework for evaluating the evidence on cessation cannot be offered.
For example, cigarette smoking causes emphysema, an irreversible destruction of the gas-exchanging structure of the lung, and permanent or only partially reversible damage to the airways of the lung. Little improvement of lung function after cessation would be anticipated for a long-term smoker with disabling chronic obstructive pulmonary disease (COPD) and extensive irreversible damage to the lung. However, cessation would benefit a smoker who has less extensive damage by slowing the rate of lung function decline and thereby reducing the likelihood of clinically significant impairment. By contrast with COPD, smoking cessation following myocardial infarction has both relatively immediate and longer term benefits. The immediately decreased risk of death in those who stop smoking in comparison with those who continue to smoke may reflect a decrease of blood coagulability, improved tissue oxygenation, and less predisposition to cardiac arrhythmias after cessation.
The findings of studies on the health consequences of smoking cessation also provide evidence relevant to determining the causality of associations of active smoking with disease. A decline in disease incidence after cessation needs to be considered as a positive indication of such a causal association. However, the pattern of changing risk after cessation must be interpreted in the context of the mechanism of disease causation by active smoking.
In interpreting individual studies on the consequences of smoking cessation, difficult methodologic and conceptual issues must be considered. Chapter 2 addresses these issues in depth. Because smoking cessation is a dynamic process, often involving multiple relapses to active smoking, accurate characterization of the former smoker is difficult and best accomplished by longitudinal observation. Misclassification of cigarette smoking status may lead to biased estimates of the consequences of smoking cessation. In observational studies and trials some subjects may report that they are former smokers, even though they continue to smoke; the resulting misclassification tends to result in underestimation of the benefits of cessation. Unraveling the consequences of smoking cessation from the effects of other factors determining the occurrence of disease poses a substantial analytical challenge. In reviewing individual reports on the consequences of smoking cessation, the approaches to these potential methodologic issues were assessed (Chapter 2). MAJOR CONCLUSIONS
More than 38 million Americans have quit smoking, and almost half of all living adults in the United States who ever smoked have quit (Volume Appendix). Nevertheless, more than 50 million Americans continue to smoke. This Report reviews in detail the health consequences of smoking cessation for those who have quit and for those who will quit in the future. The following major volume conclusions summarize the health consequences of smoking cessation for those who quit smoking in comparison with those who continue to smoke:
This Report was developed by the Office on Smoking and Health (OSH), Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control, Public Health Service of the U.S. Department of Health and Human Services, as part of the Department's responsibility under Public Law 91--222 to report new and current information on smoking and health to the U.S. Congress.
The scientific content of this Report was produced through the efforts of more than 120 scientists in the fields of medicine, psychology, the biologic and social sciences, and public health. Manuscripts for the Report, constituting drafts of chapters or sections of chapters, were prepared by 26 scientists selected for their expertise in specific content areas. An editorial team, including the Director of OSH, a medical psychologist with the Uniformed Services University of the Health Sciences, and four non-Federal experts, edited and consolidated the individual manuscripts into chapters. These draft chapters were subjected to an intensive outside peer review, with each chapter reviewed by an average of five individuals knowledgeable about the chapter's subject matter. Incorporating the reviewers' comments, the editors revised the chapters and assembled a draft of the complete Report. The draft Report was then submitted to 25 distinguished scientists for their review and comment on the entirety of its contents. Simultaneously, the draft Report was submitted to 10 institutes and agencies within the U.S. Public Health Service for review. Comments from the senior scientific reviewers and the agencies were then used to prepare the final draft of the Report, which was then reviewed by the Office of the Assistant Secretary for Health and the Secretary, Department of Health and Human Services. CHAPTER CONCLUSIONS Chapter 2: Assessing Smoking Cessation and Its Health Consequences
process of smoking cessation and relapse before attaining long-term abstinence. Any static measure of smoking status is thus a simplification of a dynamic process. 2. In studies of the health effects of smoking cessation, persons classified as former smokers may include some current smokers. Consequently, the health benefits of smoking cessation are likely to be underestimated. 3. In contexts other than intervention trials, self-reported smoking status at the time of measurement and concurrent biochemical assessment are highly concordant. This high concordance supports self-report as a valid measure of smoking status in observational studies of the health effects of smoking cessation. Chapter 3: Smoking Cessation and Overall Mortality and Morbidity
benefits of quitting extend to those who quit at older ages. For example, persons who quit smoking before age 50 have one-half the risk of dying in the next 15 years compared with continuing smokers. 2. Smoking cessation at all ages reduces the risk of premature death. 3. Among former smokers, the decline in risk of death compared with continuing smokers begins shortly after quitting and continues for at least 10 to 15 years. After 10 to 15 years of abstinence, risk of all-cause mortality returns nearly to that of persons who never smoked. 4. Former smokers have better health status than current smokers as measured in a variety of ways, including days of illness, number of health complaints, and self-reported health status. Chapter 4: Smoking Cessation and Respiratory Cancers
with continued smoking. For example, after 10 years of abstinence, the risk of lung cancer is about 30 to 50 percent of the risk in continuing smokers; with further abstinence, the risk continues to decline. 2. The reduced risk of lung cancer among former smokers is observed in males and females, in smokers of filter and nonfilter cigarettes, and for all histologic types of lung cancer. 3. Smoking cessation lowers the risk of laryngeal cancer compared with continued smoking. 4. Smoking cessation reduces the severity and extent of premalignant histologic changes in the epithelium of the larynx and lung. Chapter 5: Smoking Cessation and Nonrespiratory Cancers
cavity and esophagus, compared with continued smoking, as soon as 5 years after cessation, with further reduction over a longer period of abstinence. 2. Smoking cessation reduces the risk of pancreatic cancer, compared with continued smoking, although this reduction in risk may only be measurable after 10 years of abstinence. 3. Smoking is a cause of bladder cancer; cessation reduces risk by about 50 percent after only a few years, in comparison with continued smoking. 4. The risk of cervical cancer is substantially lower among former smokers in comparison with continuing smokers, even in the first few years after cessation. This finding supports the hypothesis that cigarette smoking is a contributing cause of cervical cancer. 5. Neither smoking nor smoking cessation are associated with the risk of cancer of the breast. Chapter 6: Smoking Cessation and Cardiovascular Disease
substantially reduces risk of coronary heart disease (CHD) among men and women of all ages. 2. The excess risk of CHD caused by smoking is reduced by about half after 1 year of smoking abstinence and then declines gradually. After 15 years of abstinence, the risk of CHD is similar to that of persons who have never smoked. 3. Among persons with diagnosed CHD, smoking cessation markedly reduces the risk of recurrent infarction and cardiovascular death. In many studies, this reduction in risk of recurrence or premature death has been 50 percent or more. 4. Smoking cessation substantially reduces the risk of peripheral artery occlusive disease compared with continued smoking. 5. Among patients with peripheral artery disease, smoking cessation improves exercise tolerance, reduces the risk of amputation after peripheral artery surgery, and increases overall survival. 6. Smoking cessation reduces the risk of both ischemic stroke and subarachnoid hemorrhage compared with continued smoking. After smoking cessation, the risk of stroke returns to the level of never smokers; in some studies this has occurred within 5 years, but in others as long as 15 years of abstinence were required. Chapter 7: Smoking Cessation and Nonmalignant Respiratory Diseases
such as cough, sputum production, and wheezing, and respiratory infections such as bronchitis and pneumonia, compared with continued smoking. 2. For persons without overt chronic obstructive pulmonary disease (COPD), smoking cessation improves pulmonary function about 5 percent within a few months after cessation. 3. Cigarette smoking accelerates the age-related decline in lung function that occurs among never smokers. With sustained abstinence from smoking, the rate of decline in pulmonary function among former smokers returns to that of never smokers. 4. With sustained abstinence, the COPD mortality rates among former smokers decline in comparison with continuing smokers. Chapter 8: Smoking Cessation and Reproduction
infants of the same birthweight as those born to never smokers. 2. Pregnant smokers who stop smoking at any time up to the 30th week of gestation have infants with higher birthweight than do women who smoke throughout pregnancy. Quitting in the first 3 to 4 months of pregnancy and abstaining throughout the remainder of pregnancy protect the fetus from the adverse effects of smoking on birthweight. 3. Evidence from two intervention trials suggests that reducing daily cigarette consumption without quitting has little or no benefit for birthweight. 4. Recent estimates of the prevalence of smoking during pregnancy, combined with an estimate of the relative risk of low birthweight outcome in smokers, suggest that 17 to 26 percent of low birthweight births could be prevented by eliminating smoking during pregnancy; in groups with a high prevalence of smoking (e.g., women with less than a high school education), 29 to 42 percent of low birthweight births might be prevented by elimination of cigarette smoking during pregnancy. 5. Approximately 30 percent of women who are cigarette smokers quit after recognition of pregnancy, with greater proportions quitting among married women and especially among women with higher levels of educational attainment. 6. Smoking causes women to have natural menopause 1 to 2 years early. Former smokers have an age at natural menopause similar to that of never smokers. Chapter 9: Smoking, Smoking Cessation, and Other Nonmalignant Diseases
duodenal and gastric ulcer, and this increased risk is reduced by smoking cessation. 2. Ulcer disease is more severe among smokers than among nonsmokers. Smokers are less likely to experience healing of duodenal ulcers and are more likely to have recurrences of both duodenal and gastric ulcers within specified timeframes. Most ulcer medications fail to alter these tendencies. 3. Smokers with gastric or duodenal ulcers who stop smoking improve their clinical course relative to smokers who continue to smoke. 4. The evidence that smoking increases the risk of osteoporotic fractures or decreases bone mass is inconclusive, with many conflicting findings. Data on smoking cessation are extremely limited at present. 5. There is evidence that smoking is associated with prominent facial skin wrinkling in whites, particularly in the periorbital ("crow's foot") and perioral areas of the face. The effect of cessation on skin wrinkling is unstudied. Chapter 10: Smoking Cessation and Body Weight Change
pounds (2.3 kg). This weight gain poses a minimal health risk. 2. Approximately 80 percent of smokers who quit gain weight after cessation, but only about 3.5 percent of those who quit smoking gain more than 20 pounds. 3. Increases in food intake and decreases in resting energy expenditure are largely responsible for postcessation weight gain. Chapter 11: Psychological and Behavioral Consequences and Correlates of Smoking Cessation
anxiety, irritability, frustration, anger, difficulty concentrating, increased appetite, and urges to smoke. With the possible exception of urges to smoke and increased appetite, these effects soon disappear. 2. Smokers who abstain from smoking show short-term impairment of performance on a variety of simple attention tasks, which improves with nicotine administration. Memory, learning, and the performance of more complex tasks have not been clearly shown to be impaired. Whether the self-reported improvement in attention tasks upon nicotine administration is due entirely to relief of withdrawal effects or is also due in part to enhancement of performance above the norm is unclear. 3. In comparison with current smokers, former smokers have a greater perceived ability to achieve and maintain smoking abstinence (self-efficacy) and a greater perceived control over personal circumstances (locus of control). 4. Former smokers, compared with current smokers, practice more health-promoting and disease-preventing behaviors. Volume Appendix: National Trends in Smoking Cessation
ROGOT, E., MURRAY, J.L. Smoking and causes of death among U.S. veterans: 16 years of observation. Public Health Reports 95(3):213-222, May-June 1980.
SCHWARTZ, J.L. Review and Evaluation of Smoking Cessation Methods: United States and Canada, 1978-1985. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, NIH Publication No. 87-2940, April 1987.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. The Health Consequences of Smoking for Women. A Report of the Surgeon General. U.S. Department of Health and Human Services, Public Health Service, Office of the Assistant Secretary for Health, Office on Smoking and Health, 1980.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. The Health Consequences of Involuntary Smoking. A Report of the Surgeon General. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control. DHHS Publication No. (CDC) 87-8398, 1986.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. The Health Consequences of Smoking: Nicotine Addiction. A Report of the Surgeon General, 1988. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Health Promotion and Education, Office on Smoking and Health. DHHS Publication No. (CDC) 88-8406, 1988.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. DHHS Publication No. (CDC) 89-8411, 1989.
U.S. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE. Smoking and Health. A Report of the Surgeon General. U.S. Department of Health, Education, and Welfare, Public Health Service, Office of the Assistant Secretary for Health, Office on Smoking and Health. DHEW Publication No. (PHS) 79-50066, 1979.
U.S. PUBLIC HEALTH SERVICE. Smoking and Health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control. PHS Publication No. 1103, 1964.
WEST, S., MUNOZ, B., EMMETT, E.A., TAYLOR, H.R. Cigarette smoking and risk of nuclear cataracts. Archives of Ophthalmology 107(8):1166-1169, August 1989.
Disclaimer All MMWR HTML documents published before January 1993 are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.**Questions or messages regarding errors in formatting should be addressed to email@example.com.
Page converted: 08/05/98
This page last reviewed 5/2/01